Thermo Fisher Scientific Inc

TMO

Equity

ISIN null / Valor 977576

New York Stock Exchange, Inc (2025-10-17)

USD 538.92+0.40%

Thermo Fisher Scientific Inc
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Thermo Fisher Scientific Inc. is a prominent global provider of scientific instruments, reagents, and laboratory services, catering to the life sciences, biotechnology, and pharmaceutical sectors. With annual revenues exceeding $40 billion and a workforce of over 90,000 employees, the company offers a comprehensive range of products and services through its well-known brands such as Thermo Scientific, Applied Biosystems, Invitrogen, and Fisher Scientific. Thermo Fisher supports diverse scientific endeavors, including life sciences research, analytical challenges, diagnostics, and the development and manufacturing of therapies. Additionally, the company provides extensive pharmaceutical services, including contract development and manufacturing (CDMO), clinical trial solutions, and end-to-end drug development offerings that encompass active pharmaceutical ingredients (API), biologics, and commercial manufacturing across more than 65 global locations.

Summarized from source with an LLMView SourceSector: Technology

Revenue Growth

Second quarter revenue increased by 3% to $10.85 billion, up from $10.54 billion in the same quarter of 2024, with organic revenue growth of 2%.

Earnings per Share

GAAP diluted earnings per share rose by 6% to $4.28, while adjusted EPS was reported at $5.36.

Operational Excellence

The company delivered excellent operational performance by effectively managing costs and leveraging the PPI Business System to navigate the macroeconomic environment.

Strategic Partnerships

Thermo Fisher expanded its strategic partnership with Sanofi by acquiring the Ridgefield, New Jersey sterile fill-finish site, enhancing U.S. capacity to meet the growing demands of pharma and biotech customers.